Virios Therapeutics Llc
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for… Read more
Market Cap & Net Worth: Virios Therapeutics Llc (VIRI)
Virios Therapeutics Llc (NASDAQ:VIRI) has a market capitalization of $3.16 Million ($3.16 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #39377 globally and #12828 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Virios Therapeutics Llc's stock price $2.37 by its total outstanding shares 1332270 (1.33 Million).
Virios Therapeutics Llc Market Cap History: 2020 to 2024
Virios Therapeutics Llc's market capitalization history from 2020 to 2024. Data shows change from $250.13 Million to $3.16 Million (-72.80% CAGR).
Index Memberships
Virios Therapeutics Llc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2868 of 3165 |
Weight: Virios Therapeutics Llc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Virios Therapeutics Llc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Virios Therapeutics Llc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VIRI by Market Capitalization
Companies near Virios Therapeutics Llc in the global market cap rankings as of March 19, 2026.
Key companies related to Virios Therapeutics Llc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Virios Therapeutics Llc Historical Marketcap From 2020 to 2024
Between 2020 and today, Virios Therapeutics Llc's market cap moved from $250.13 Million to $ 3.16 Million, with a yearly change of -72.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $3.16 Million | -83.51% |
| 2023 | $19.15 Million | +143.64% |
| 2022 | $7.86 Million | -95.39% |
| 2021 | $170.36 Million | -31.89% |
| 2020 | $250.13 Million | -- |
End of Day Market Cap According to Different Sources
On Dec 5th, 2025 the market cap of Virios Therapeutics Llc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.16 Million USD |
| MoneyControl | $3.16 Million USD |
| MarketWatch | $3.16 Million USD |
| marketcap.company | $3.16 Million USD |
| Reuters | $3.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.